Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test-Reference-Cited by-同舟云学术

Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test

Published:2019-06-04 Issue:3 Volume:9 Page:505-510
ISSN:2193-8210
Container-title:Dermatology and Therapy
language:en
Short-container-title:Dermatol Ther (Heidelb)

Author:

Villani Alessia,Fabbrocini Gabriella,Cappello Milena,Costa Claudia,Scalvenzi Massimiliano

Publisher

Springer Science and Business Media LLC

Subject

Dermatology

Link

http://link.springer.com/content/pdf/10.1007/s13555-019-0303-4.pdf

Reference18 articles.

1. Gaulin C, Sebaratnam DF, Fernández-Peñas P. Quality of life in non-melanoma skin cancer. Australas J Dermatol. 2015;56(1):70–6.

2. Abedini R, Nasimi M, Noormohammad Pour P, Moghtadaie A, Tohidinik HR. Quality of life in patients with non-melanoma skin cancer: implications for healthcare education services and supports. J Cancer Educ. 2018. https://doi.org/10.1007/s13187-018-1368-y .

3. Scalvenzi M, Villani A, Mazzella C, Cappello M, Salvatores GF, Costa C. Vismodegib treatment in a HIV positive patient on antiretroviraltherapy. Indian J Dermatol Venereol Leprol. 2018;84(6):758–60.

4. Basset-Séguin N, Hauschild A, Kunstfeld R, et al. Vismodegib in patients with advanced basal cell carcinoma: primary analysis of STEVIE, an international, open-label trial. Eur J Cancer. 2017;86:334–48.

5. Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB. Development of the facial skin care index: a health-related outcomes index for skin cancer patients. Dermatol Surg. 2006;32(7):924–34.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality of life in cemiplimab-treated patients with locally advanced basal cell carcinoma in a Phase II clinical trial;Future Oncology;2024-07-29

3. Efficacy and Safety of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: An Updated Systematic Review and Meta-analysis (2009–2022);American Journal of Clinical Dermatology;2023-02-16

4. A systematic review of patient-reported outcome measures for advanced skin cancer patients;Archives of Dermatological Research;2022-12-05

5. New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma;Advances in Therapy;2022-01-28